GDP Update 2026

Details

Good Distribution Practice (GDP) comprises measures within the pharmaceutical supply chain to ensure the quality and integrity of medicinal products and active pharmaceutical ingredients (APIs). Regulatory requirements for the distribution of medicinal products and APIs have steadily increased, affecting not only storage, transport, and distribution companies and wholesalers but also manufacturers. To meet these growing demands, regular training for all stakeholders is essential.

In recent months, there have been numerous updates and innovations in the field of GDP. This webinar has been designed to provide a structured and comprehensive overview. It includes a presentation followed by a Q&A session, allowing participants to address their questions.

This webinar aims to give a comprehensive yet compact overview of current requirements and latest developments in GDP – those already realized and those planned:

• „Regulatory updates – Changes in regulations, guidelines, and publications from authorities and organizations over the past 12 months
• Insights from the European GDP Association
• GDP Compliance – Overview of key requirements, responsibilities, and essential documents/SOPs
• GDP Non-Compliance Reports 2025 – Key findings and preventive measures
• Lessons from GDP inspections – Common pitfalls and how to avoid them
• Outlook for 2026

This e-learning course is based on a webinar held live on 12.03.2026 by Concept Heidelberg.